about
Targeted therapy using nanotechnology: focus on cancerNasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors.Nanoparticle therapeutics for prostate cancer treatment.Resveratrol nanoformulation for cancer prevention and therapy.Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities.Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies.Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.Inhibitory Effect of 2,3,5,6-Tetrafluoro-4-[4-(aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide Derivatives on HIV Reverse Transcriptase Associated RNase H Activities.Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function.Bilayer tablets based on poly (epsilon-caprolactone) and polymethylmethacrilates as controlled-release systems for ruminants.Synthesis and evaluation of different fatty acid esters formulated into Precirol ATO-Based lipid nanoparticles as vehicles for topical delivery.Effect of vehicle on diclofenac sodium permeation from new topical formulations: in vitro and in vivo studies.Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate.Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells.Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: preliminary studies.Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors.Multifunctionalization of wool fabrics through nanoparticles: A chemical route towards smart textiles.Effect of chitosan concentration on PLGA microcapsules for controlled release and stability of resveratrol.Photothermal Membrane Distillation for Seawater Desalination.Nanoencapsulation of dietary flavonoid fisetin: Formulation and in vitro antioxidant and α-glucosidase inhibition activities.Graphene-containing thermoresponsive nanocomposite hydrogels of poly(N-isopropylacrylamide) prepared by frontal polymerizationOvercoming temperature polarization in membrane distillation by thermoplasmonic effects activated by Ag nanofillers in polymeric membranesPolymeric Nanoparticles Encapsulating White Tea Extract for Nutraceutical ApplicationSolid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies
P50
Q27023361-1B25CCA7-44CE-4F20-878A-0372D80011C4Q33226222-BF00CE38-DF3E-4A18-95EF-304D9B94FF4DQ35960631-0CC77528-C3A9-464E-AD4C-238482DAC70EQ38013931-94495B1F-BA85-449B-9952-01C78660AB15Q38537318-B4D36C9B-FCCC-4BE0-8265-40C564548E4AQ38758194-6E850748-EF78-4BEE-A62C-3E9B13782B04Q38818143-19E3DBC9-07F7-4E59-8AD3-5D6FF90D2F1EQ38943270-708211C5-6D3C-4EBD-982A-088B161343D7Q38987405-6C3B58DB-43C0-4F90-AEED-C4F71D386387Q38993209-8AA83A3A-8172-427D-9118-9972CF46EACEQ39106653-75439B1A-FDF0-46E6-952F-C3451261BA66Q39595425-099D962B-D3EC-4890-A035-324292B567B1Q40953028-5218F9A5-7482-45A5-883F-D9B00329DAD9Q43646847-CAAE719B-9BD1-47E7-BCE8-61B5EFE5DC80Q44252785-A04FCEEC-847F-44CC-A14F-E7E50B7AC666Q44284991-24EFCC23-C5F4-4544-897C-7B4092733A25Q45085648-E61291F8-8906-4814-8445-B4AFA9CE0A1AQ45943143-B13E3DAC-3DE8-44DA-B42C-BC79C1E52EE5Q46023951-4E6886D2-75D8-4A99-BB7A-8108394A61BFQ46030448-AA89958D-9318-4A0E-95BB-3A936327C86EQ46419767-8B437AD0-008B-4E4A-8799-977400C60989Q46770005-1A7DB57A-D424-4FDC-8D69-00C94521ECD4Q46862734-EAE791DB-E9F7-4543-8E09-8D2861AE1100Q49838240-25D49C2C-6E51-41E6-82C9-7EA1A8C6375DQ50212790-5B659755-57FD-43A9-9969-4E4F68AF0D50Q51053885-7C04BF72-92DD-42CB-9FC4-895FF702C9DAQ51054983-5376CBF5-15A6-4309-B7A5-5CD2F657AC08Q51200794-DEBE49D4-E974-481D-AE82-316275775EAAQ56030489-10264037-BD4F-414A-9608-4AFB000C5803Q61054746-79AD1C53-C20D-4A21-95EF-274731DD89D9Q61054755-12396B4F-6A4C-46E8-AD42-8938A89AD256Q61054772-E2F5ACC2-D707-45B4-BA1D-7AE0FAC4D8A1
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vanna Sanna
@ast
Vanna Sanna
@en
Vanna Sanna
@es
Vanna Sanna
@nl
Vanna Sanna
@sl
type
label
Vanna Sanna
@ast
Vanna Sanna
@en
Vanna Sanna
@es
Vanna Sanna
@nl
Vanna Sanna
@sl
prefLabel
Vanna Sanna
@ast
Vanna Sanna
@en
Vanna Sanna
@es
Vanna Sanna
@nl
Vanna Sanna
@sl
P106
P21
P31
P496
0000-0001-9068-6349